RMP (Risk Management Plan)
What does it mean in plain English?
A Risk Management Plan (RMP) is a formal document every medicine has to submit alongside its marketing authorization application. It lays out everything already known about the drug's risks, what's still uncertain, and exactly how the company plans to keep watching for new problems once real patients start taking it.
It isn't a one-time document. It gets updated throughout the medicine's life as new safety data comes in, whether from spontaneous reports, post-authorization studies, or a fresh PRAC review. Everything defined in the RMP has a job to do: identify a risk, minimize it, or communicate it clearly to prescribers and patients.
Open the binder
An RMP is really a handful of chapters bundled together. Hover each tab to see what's inside.
Hover a tab to slide it openEverything already known about the drug's risks, from clinical trials and everything similar drugs have shown before.
How safety data will keep getting collected after launch: routine monitoring, or extra studies if a risk needs closer watching.
What's actually being done to reduce known risks: label warnings, prescriber guides, patient safety cards, restricted access.
A plain-language version of the whole plan, required in the EU so patients can actually read it too.
Common Misconceptions
"A whole formal plan just for risks? Does that mean this particular drug is unusually dangerous?"
No, every single medicine needs an RMP, regardless of how safe it is. It's a standard requirement, not a red flag. Think of it less as a warning sign and more as routine due diligence, the same seatbelt-and-airbag paperwork every new car needs before it can be sold.
